Lacosamide
Top View
- CDR Clinical Review Report on Aptiom
- Diapositiva 1
- Evaluation of Carcinogenicity Studies of Medicinal Products for Human Use Authorised Via the European Centralised Procedure
- VIMPAT Label
- Therapeutic Class Overview Neuropathic Pain Agents
- Aeds and the RNS System
- Appendix A. Table A1. Pharmacological Classes for Migraine Prevention
- A Summary of Antiseizure Medications Available in the United States: 2020 Update
- Effect of Lacosamide and Ethosuximide Chronic Treatment on Neural Precursor Cells and Cognitive Functions After Pilocarpine Induced Status Epilepticus in Mice
- Ventricular Tachycardia Associated with Lacosamide Co-Medication in Drug-Resistant Epilepsy
- Interactions Among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice
- Manipulation of Medicinal Products for Oral Administration to Paediatric Patients at a German University Hospital: an Observational Study
- Rational Polytherapy?
- Lacosamide Injection
- Efficacy and Safety of Adjunctive Lacosamide in the Treatment of Primary Generalised Tonic-Clonic Seizures
- LAMICTAL XR Safely and Effectively
- Prescribing Information | VIMPAT® (Lacosamide) CV
- Drugs of Abuse, a DEA Resource Guide (2020 Edition)